Profile for Anika Therapeutics Inc. (ANIK)

$ 53.12   -0.61 (-1.14%) Volume: 420.19k 4:00 PM EDT 20-Sep-2019
After Hours:  $ 53.12 0.00 (0.00%) Volume: 65.91k 5:01 PM EDT 20-Sep-2019
Business Description:
Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
Address: 32 Wiggins Avenue, Bedford, MA, USA, 01730
Telephone: +1 781 457-9000 Website:
Facsimile: +1 781 305-9720 Email: [email protected]
CEO: Joseph G. Darling
Employees: 133 Market Cap: 732.15m
Issue Type: CS
Auditor: Deloitte & Touche LLP
Last Audit: Unqualified Opinion
Indices: Biotechnology, Morningstar US Market Factor Tilt PR USD, Morningstar US Market Factor Tilt TR USD, S&P Top 1000
Industry Classifications
Sector: Healthcare CIK: 898437
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Surgical And Medical Instruments And Apparatus (3841)